TransMedics up after Piper Sandler PT rise
Shares of medtech company TransMedics Group TMDX.O rise 1.6% to $130.79
Piper Sandler raises TMDX's PT to $145 from $125
Piper believes TMDX is on track to beat sales estimates for Q2, which could continue stock's strong momentum seen in recent months
While there was a slight decline in plane volumes in May compared to April, brokerage believes TMDX continues to see strong adoption of its aviation services
TMDX still appears positioned to deliver sequential quarterly growth in its logistics business given May flight volumes were higher than each month in Q1 - Piper
TMDX up 106.5% YTD, as of last close
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Recommended Articles
Featured Tools
Top News
TSLA Q1 Earnings Preview: Tesla Snaps 8-Week Slump—Now Buy the Dip or Wait?

Why AMD Stock Popped: 12-Day Winning Rally Signals CPU Renaissance in Agentic AI Push

APLD Stock Surge: How CoreWeave Lease Amendments and Delta Forge 1 Milestones De-risk the Bull Case

AI Chip Startup Cerebras Refiles for IPO, Testing Nvidia’s Pricing Power

GPT-Rosalind Sparks CRO Sector Slump: Should Investors Buy the Dip or Exit Amid AI Drug R&D Impact?

Tradingkey







